메뉴 건너뛰기




Volumn 57, Issue 1, 2011, Pages 63-68

A prognostic evaluation of vascular endothelial growth factor in children and young adults with osteosarcoma

Author keywords

Children; Osteosarcoma; Prognostic factor; VEGF

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; METHOTREXATE; VASCULOTROPIN A;

EID: 79955722714     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23021     Document Type: Article
Times cited : (24)

References (29)
  • 3
    • 0028125701 scopus 로고
    • Prognostic factors in osteosarcoma: A critical review
    • Davis AM, Bell RS, Goodwin PJ. Prognostic factors in osteosarcoma: A critical review. J Clin Oncol 1994; 12: 423-431.
    • (1994) J Clin Oncol , vol.12 , pp. 423-431
    • Davis, A.M.1    Bell, R.S.2    Goodwin, P.J.3
  • 4
    • 33644505791 scopus 로고    scopus 로고
    • Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution
    • Bacci G, Longhi A, Versari M, et al. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 2006; 1: 1154-1161.
    • (2006) Cancer , vol.1 , pp. 1154-1161
    • Bacci, G.1    Longhi, A.2    Versari, M.3
  • 5
    • 0028888760 scopus 로고
    • Clinical relevance of Ki-67 expression in bone tumors
    • Scotlandi K, Serra M, Manara MC, et al. Clinical relevance of Ki-67 expression in bone tumors. Cancer 1995; 1: 806-814.
    • (1995) Cancer , vol.1 , pp. 806-814
    • Scotlandi, K.1    Serra, M.2    Manara, M.C.3
  • 6
    • 36049027674 scopus 로고    scopus 로고
    • Prognostic value of P-glycoprotein in high-grade osteosarcoma
    • Serra M, Picci P, Ferrari S, Bacci G. Prognostic value of P-glycoprotein in high-grade osteosarcoma. J Clin Oncol 2007; 20: 4858-4860.
    • (2007) J Clin Oncol , vol.20 , pp. 4858-4860
    • Serra, M.1    Picci, P.2    Ferrari, S.3    Bacci, G.4
  • 7
    • 18844467502 scopus 로고    scopus 로고
    • Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis
    • Kaya M, Wada T, Akatsuka T, et al. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res 2000; 6: 572-577.
    • (2000) Clin Cancer Res , vol.6 , pp. 572-577
    • Kaya, M.1    Wada, T.2    Akatsuka, T.3
  • 8
    • 4344583344 scopus 로고    scopus 로고
    • What makes vessels grow with exercise training?
    • Prior BM, Yang HT, Terjung RL. What makes vessels grow with exercise training? J App Physiol 2004; 97: 1119-1128.
    • (2004) J App Physiol , vol.97 , pp. 1119-1128
    • Prior, B.M.1    Yang, H.T.2    Terjung, R.L.3
  • 9
    • 72849123834 scopus 로고    scopus 로고
    • Vascular endothelial growth factor in children with neuroblastoma: A retrospective analysis
    • Jakovljević G, Culić S, Stepan J, et al. Vascular endothelial growth factor in children with neuroblastoma: A retrospective analysis. J Exp Clin Cancer Res 2009; 6: 143.
    • (2009) J Exp Clin Cancer Res , vol.6 , pp. 143
    • Jakovljević, G.1    Culić, S.2    Stepan, J.3
  • 10
    • 33749187067 scopus 로고    scopus 로고
    • The prognostic significance of angiogenesis and the effect of vascular endothelial growth factor on angiogenic process in Wilms' tumour
    • Ozluk Y, Kilicaslan I, Gulluoglu MG, et al. The prognostic significance of angiogenesis and the effect of vascular endothelial growth factor on angiogenic process in Wilms' tumour. Pathology 2006; 38: 408-414.
    • (2006) Pathology , vol.38 , pp. 408-414
    • Ozluk, Y.1    Kilicaslan, I.2    Gulluoglu, M.G.3
  • 11
    • 14644440555 scopus 로고    scopus 로고
    • Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
    • Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005; 10: 1011-1027.
    • (2005) J Clin Oncol , vol.10 , pp. 1011-1027
    • Hicklin, D.J.1    Ellis, L.M.2
  • 12
    • 0037163646 scopus 로고    scopus 로고
    • The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy
    • Manders P, Beex LV, Tjan-Heijnen VC, et al. The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy. Br J Cancer 2002; 87: 772-778.
    • (2002) Br J Cancer , vol.87 , pp. 772-778
    • Manders, P.1    Beex, L.V.2    Tjan-Heijnen, V.C.3
  • 13
    • 0034075041 scopus 로고    scopus 로고
    • Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients
    • Lee JC, Chow NH, Wang ST, et al. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer 2000; 36: 748-753.
    • (2000) Eur J Cancer , vol.36 , pp. 748-753
    • Lee, J.C.1    Chow, N.H.2    Wang, S.T.3
  • 14
    • 0030996171 scopus 로고    scopus 로고
    • Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: A prospective study
    • Fontanini G, Lucchi M, Vignati S, et al. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: A prospective study. J Natl Cancer Inst 1997; 89: 881-886.
    • (1997) J Natl Cancer Inst , vol.89 , pp. 881-886
    • Fontanini, G.1    Lucchi, M.2    Vignati, S.3
  • 15
    • 37549040613 scopus 로고    scopus 로고
    • Paclitaxel pus bevacizumab versus paclitaxel alone for metastatic breast cancer
    • Miller K, Wang M, Gralow J, et al. Paclitaxel pus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med 2007; 357: 2666-2676.
    • (2007) N Engl J Med , vol.357 , pp. 2666-2676
    • Miller, K.1    Wang, M.2    Gralow, J.3
  • 16
    • 55249100794 scopus 로고    scopus 로고
    • Bevacizumab: direct anti-VEGF therapy in renal cell carcinoma
    • Escudier B, Cosaert J, Pisa P. Bevacizumab: direct anti-VEGF therapy in renal cell carcinoma. Expert Rev Anticancer Ther 2008; 8: 1545-1557.
    • (2008) Expert Rev Anticancer Ther , vol.8 , pp. 1545-1557
    • Escudier, B.1    Cosaert, J.2    Pisa, P.3
  • 17
    • 2542561964 scopus 로고    scopus 로고
    • Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    • Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342.
    • (2004) N Engl J Med , vol.350 , pp. 2335-2342
    • Hurwitz, H.1    Fehrenbacher, L.2    Novotny, W.3
  • 18
    • 77958465052 scopus 로고    scopus 로고
    • Bevacizumab: Current updates in treatment
    • Van Meter ME, Kim ES. Bevacizumab: Current updates in treatment. Curr Opin Oncol 2010; 22: 586-591.
    • (2010) Curr Opin Oncol , vol.22 , pp. 586-591
    • Van Meter, M.E.1    Kim, E.S.2
  • 20
    • 79960328502 scopus 로고    scopus 로고
    • Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma
    • Epub ahead of print].
    • Lin F, Zheng SE, Shen Z, et al., Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma. Med Oncol 2010 [Epub ahead of print].
    • (2010) Med Oncol
    • Lin, F.1    Zheng, S.E.2    Shen, Z.3
  • 21
    • 33645758312 scopus 로고    scopus 로고
    • Outcome of patients with osteosarcoma over 40 years of age: Is angiogenesis a marker of survival?
    • Ek ET, Ojaimi J, Kitagawa Y, et al. Outcome of patients with osteosarcoma over 40 years of age: Is angiogenesis a marker of survival? Int Semin Surg Oncol 2006; 21: 7.
    • (2006) Int Semin Surg Oncol , vol.21 , pp. 7
    • Ek, E.T.1    Ojaimi, J.2    Kitagawa, Y.3
  • 22
    • 0034923620 scopus 로고    scopus 로고
    • Lack of prognostic significance of intratumoral angiogenesis in nonmetastatic osteosarcoma
    • Mantadakis E, Kim G, Reisch J. Lack of prognostic significance of intratumoral angiogenesis in nonmetastatic osteosarcoma. J Pediatr Hematol Oncol 2001; 23: 286-289.
    • (2001) J Pediatr Hematol Oncol , vol.23 , pp. 286-289
    • Mantadakis, E.1    Kim, G.2    Reisch, J.3
  • 23
    • 11144245499 scopus 로고    scopus 로고
    • Prognostic relevance of increased angiogenesis in osteosarcoma
    • Kreuter M, Bieker R, Bielack SS, et al. Prognostic relevance of increased angiogenesis in osteosarcoma. Clin Cancer Res 2004; 10: 8531-8537.
    • (2004) Clin Cancer Res , vol.10 , pp. 8531-8537
    • Kreuter, M.1    Bieker, R.2    Bielack, S.S.3
  • 24
    • 0020517706 scopus 로고
    • Morphological grades of regression in osteosarcoma after polychemotherapy-Study COSS 80
    • Salzer-Kuntschik M, Delling G, Beron G, Sigmund R. Morphological grades of regression in osteosarcoma after polychemotherapy-Study COSS 80. J Cancer Res Clin Oncol 1983; 106. (Suppl:21-4).
    • (1983) J Cancer Res Clin Oncol , vol.106 , Issue.SUPPL. 21-4
    • Salzer-Kuntschik, M.1    Delling, G.2    Beron, G.3    Sigmund, R.4
  • 25
    • 53949112697 scopus 로고    scopus 로고
    • Prognostic significance of alpha V integrin and VEGF in osteosarcoma after chemotherapy
    • Huang Y, Lin Z, Zhuang J. Prognostic significance of alpha V integrin and VEGF in osteosarcoma after chemotherapy. Onkologie 2008; 31: 535-540.
    • (2008) Onkologie , vol.31 , pp. 535-540
    • Huang, Y.1    Lin, Z.2    Zhuang, J.3
  • 26
    • 77949419636 scopus 로고    scopus 로고
    • Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: An immunohistochemical analysis
    • Rossi B, Schinzari G, Maccauro G. Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: An immunohistochemical analysis. BMC Musculoskelet Disord 2010; 16: 34.
    • (2010) BMC Musculoskelet Disord , vol.16 , pp. 34
    • Rossi, B.1    Schinzari, G.2    Maccauro, G.3
  • 27
    • 0033166894 scopus 로고    scopus 로고
    • Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma
    • Lee YH, Tokunaga T, Oshika Y, et al. Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer 1999; 35: 1089-1093.
    • (1999) Eur J Cancer , vol.35 , pp. 1089-1093
    • Lee, Y.H.1    Tokunaga, T.2    Oshika, Y.3
  • 28
    • 33646125873 scopus 로고    scopus 로고
    • CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: Analysis within a group of patients, all of whom developed lung metastasis
    • Oda Y, Yamamoto H, Tamiya S. CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: Analysis within a group of patients, all of whom developed lung metastasis. Mod Pathol 2006; 19: 738-745.
    • (2006) Mod Pathol , vol.19 , pp. 738-745
    • Oda, Y.1    Yamamoto, H.2    Tamiya, S.3
  • 29
    • 5044223651 scopus 로고    scopus 로고
    • Tumor angiogenesis and outcome in osteosarcoma
    • Mikulić D, Ilić I, Cepulić M. et al. Tumor angiogenesis and outcome in osteosarcoma. Pediatr Hematol Oncol 2004; 21: 611-619.
    • (2004) Pediatr Hematol Oncol , vol.21 , pp. 611-619
    • Mikulić, D.1    Ilić, I.2    Cepulić, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.